Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Cost of Revenue (2023 - 2025)

Historic Cost of Revenue for Atara Biotherapeutics (ATRA) over the last 3 years, with Q3 2025 value amounting to $115000.0.

  • Atara Biotherapeutics' Cost of Revenue fell 9848.72% to $115000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $27.9 million, marking a year-over-year increase of 6060.2%. This contributed to the annual value of $21.0 million for FY2024, which is 13642.81% up from last year.
  • Latest data reveals that Atara Biotherapeutics reported Cost of Revenue of $115000.0 as of Q3 2025, which was down 9848.72% from $554000.0 recorded in Q2 2025.
  • In the past 5 years, Atara Biotherapeutics' Cost of Revenue registered a high of $20.4 million during Q1 2025, and its lowest value of $115000.0 during Q3 2025.
  • Moreover, its 3-year median value for Cost of Revenue was $2.9 million (2023), whereas its average is $4.6 million.
  • Examining YoY changes over the last 5 years, Atara Biotherapeutics' Cost of Revenue showed a top increase of 92967.25% in 2025 and a maximum decrease of 9848.72% in 2025.
  • Over the past 3 years, Atara Biotherapeutics' Cost of Revenue (Quarter) stood at $3.2 million in 2023, then skyrocketed by 115.03% to $6.8 million in 2024, then crashed by 98.31% to $115000.0 in 2025.
  • Its Cost of Revenue stands at $115000.0 for Q3 2025, versus $554000.0 for Q2 2025 and $20.4 million for Q1 2025.